DECAPEPTYL

This brand name is authorized in Austria, Australia, Ecuador, Spain, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug DECAPEPTYL contains one active pharmaceutical ingredient (API):

1 Triptorelin
UNII 43OFW291R9 - TRIPTORELIN ACETATE

Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins.

Read about Triptorelin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DECAPEPTYL SR Powder for suspension for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DECAPEPTYL SR Powder and solvent for suspension for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L02AE04 Triptorelin L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10907C
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 22.592-1-05-06, 28799-03-09, 5159-MEE-0520, 5342-MEE-0720
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 58404, 61665, 62431, 72077
Country: FR Base de données publique des médicaments Identifier(s): 60092811, 62842966, 64460075, 64528487, 65085347, 65459503, 67699931, 67772596, 69278094
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 184797, 388432, 393601, 396233, 41466, 81729
Country: HK Department of Health Drug Office Identifier(s): 33730, 36917
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-441368305, HR-H-750053749
Country: IE Health Products Regulatory Authority Identifier(s): 88030, 88031, 88632, 88716, 88821, 89009, 89037, 89126
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4021, 4991, 631, 7850
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1021092
Country: NL Z-Index G-Standaard Identifier(s): 13847562, 14068125
Country: NL Z-Index G-Standaard, PRK Identifier(s): 105732, 39683, 70084
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100017285, 100108881
Country: SG Health Sciences Authority Identifier(s): 08697P, 09105P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5723023, 5723024, 5723025H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8697621270053, 8697621950047
Country: ZA Health Products Regulatory Authority Identifier(s): 28/21.10/242

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.